
NEWSMAX @NEWSMAX
Drugmaker Pfizer and France's Valneva will stop testing a Lyme disease vaccine in roughly half of U.S. patients in a late-stage study, the companies said, citing a breach of clinical trial guidelines by a third-party contractor. https://t.co/F7c6u3Gye5 https://t.co/DLyPI8pien — PolitiTweet.org